Detalhe da pesquisa
1.
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin.
N Engl J Med
; 389(4): 297-308, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356066
2.
Once-Weekly Insulin Icodec With Dosing Guide App Versus Once-Daily Basal Insulin Analogues in Insulin-Naive Type 2 Diabetes (ONWARDS 5) : A Randomized Trial.
Ann Intern Med
; 176(11): 1476-1485, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748181
3.
Rationale and design of the phase 3a development programme (ONWARDS 1-6 trials) investigating once-weekly insulin icodec in diabetes.
Diabetes Obes Metab
; 25(2): 331-341, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106652
4.
Weekly Icodec versus Daily Glargine U100 in Type 2 Diabetes without Previous Insulin. Reply.
N Engl J Med
; 389(16): 1533, 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851884
5.
Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100.
Diabetes Obes Metab
; 23(8): 1983-1988, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830626
6.
Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE.
BMJ Open Diabetes Res Care
; 9(2)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34819298
7.
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.
Diabetes Care
; 44(7): 1586-1594, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33875485